Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation
Status:
Completed
Trial end date:
2002-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Captopril may protect the lungs from the side effects of bone marrow or stem cell
transplantation.
PURPOSE: Randomized phase III trial to determine the effectiveness of captopril to lessen the
side effects in patients who are undergoing bone marrow or stem cell transplantation
following chemotherapy and radiation therapy.